Ketoconazole: a review of its therapeutic efficacy in superficial and systemic fungal infections.
D000284:Administration, Oral; D000328:Adult; D000818:Animals; D000935:Antifungal Agents / Q000627:therapeutic use*; D001759:Blastomycosis / Q000188:drug therapy; D002177:Candidiasis / Q000188:drug therapy; D002675:Child, Preschool; D002986:Clinical Trials as Topic; D003047:Coccidioidomycosis / Q000188:drug therapy; D003453:Cryptococcosis / Q000188:drug therapy; D003881:Dermatomycoses / Q000188:drug therapy; D004305:Dose-Response Relationship, Drug; D005260:Female; D005658:Fungi / Q000187:drug effects; D006168:Guinea Pigs; D006660:Histoplasmosis / Q000188:drug therapy; D006801:Humans; D007093:Imidazoles / Q000008:administration & dosage / Q000009:adverse effects / Q000097:blood / Q000627:therapeutic use*; D007654:Ketoconazole; D007928:Lethal Dose 50; D008297:Male; D051379:Mice; D009181:Mycoses / Q000188:drug therapy*; D010879:Piperazines / Q000008:administration & dosage / Q000009:adverse effects / Q000097:blood / Q000627:therapeutic use*; D011247:Pregnancy; D012098:Reproduction / Q000187:drug effects
D000935:Antifungal Agents; D007093:Imidazoles; D010879:Piperazines; D007654:Ketoconazole